Johnson, Douglas B <br/><br/>
Continued Poor Survival in Metastatic Uveal Melanoma: Implications for Molecular Prognostication, Surveillance Imaging, Adjuvant Therapy, and Clinical Trials.  [electronic resource] 

 -  JAMA ophthalmology  09 2018 
 - 986-988 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>2168-6173 
<br/><br/><label>Standard No.: </label>10.1001/jamaophthalmol.2018.1813  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Combined Modality Therapy<br/>Humans<br/>Melanoma<br/>Survival Rate<br/>Uveal Neoplasms<br/>Uveal Melanoma